| Literature DB >> 29340308 |
Mohammed Siddiqui1, Loretta Bradford2, Jennifer Kaley3, Gina Johnson3, Kevin H Kim4, Kristen Addis4, Manisha Singh1.
Abstract
Entities:
Year: 2017 PMID: 29340308 PMCID: PMC5762936 DOI: 10.1016/j.ekir.2017.07.014
Source DB: PubMed Journal: Kidney Int Rep ISSN: 2468-0249
Figure 1Exit site lesion.
Figure 2The histopathological findings demonstrated skin with overlying parakeratosis and slight epidermal hyperplasia. There was epidermal edema with exocytosis, and focally, increased numbers of Langerhans cells. Within the dermis, there are mixed inflammatory infiltrate with scattered eosinophils.
Figure 3Resolved lesion.
Review of known cases of noninfectious exit site lesions
| Number of Cases | Authors | Agent identified | Rash description | Measures taken |
|---|---|---|---|---|
| 1 | Gosmanova | Gentamicin-induced contact dermatitis | Ovoid crusted plaque, violaceous in color with a peripheral rim of erythema and without granulation | Stopping gentamicin cream and initiating hydrocortisone 2.5% cream. |
| 2 | Yavascan | Povidone iodine | Patchy and linear erythema | Daily topical application of normal saline solution |
| 1 | Chasset | Povidone iodine | Bullous periumbilical eruption | Substitution of Betadine by chlorhexidine |
| 1 | Schmitt | Octenisept | Expanding erythematous rash | Avoiding the responsible allergen |
| 1 | Kurihara | Silicone rubber | Eczematous skin rash | Antihistaminic ointment and insert a piece of gauze under the lesion |